NM_015352.2:c.542+11G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015352.2(POFUT1):​c.542+11G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0184 in 1,578,646 control chromosomes in the GnomAD database, including 330 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 28 hom., cov: 32)
Exomes 𝑓: 0.019 ( 302 hom. )

Consequence

POFUT1
NM_015352.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.22

Publications

1 publications found
Variant links:
Genes affected
POFUT1 (HGNC:14988): (protein O-fucosyltransferase 1) This gene encodes a member of the glycosyltransferase O-Fuc family. This enzyme adds O-fucose through an O-glycosidic linkage to conserved serine or threonine residues in the epidermal growth factor-like repeats of a number of cell surface and secreted proteins. O-fucose glycans are involved in ligand-induced receptor signaling. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
POFUT1 Gene-Disease associations (from GenCC):
  • Dowling-Degos disease 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Dowling-Degos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 20-32216732-G-C is Benign according to our data. Variant chr20-32216732-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1170434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2156/152266) while in subpopulation NFE AF = 0.02 (1357/68018). AF 95% confidence interval is 0.0191. There are 28 homozygotes in GnomAd4. There are 1108 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015352.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POFUT1
NM_015352.2
MANE Select
c.542+11G>C
intron
N/ANP_056167.1
POFUT1
NM_172236.2
c.542+11G>C
intron
N/ANP_758436.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POFUT1
ENST00000375749.8
TSL:1 MANE Select
c.542+11G>C
intron
N/AENSP00000364902.3
POFUT1
ENST00000375730.3
TSL:1
c.542+11G>C
intron
N/AENSP00000364882.3
POFUT1
ENST00000465791.1
TSL:3
n.57+11G>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2156
AN:
152148
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00439
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.00831
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0409
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0199
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.0144
AC:
3612
AN:
251064
AF XY:
0.0144
show subpopulations
Gnomad AFR exome
AF:
0.00381
Gnomad AMR exome
AF:
0.00571
Gnomad ASJ exome
AF:
0.00110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0413
Gnomad NFE exome
AF:
0.0203
Gnomad OTH exome
AF:
0.0150
GnomAD4 exome
AF:
0.0188
AC:
26881
AN:
1426380
Hom.:
302
Cov.:
25
AF XY:
0.0183
AC XY:
13022
AN XY:
711792
show subpopulations
African (AFR)
AF:
0.00287
AC:
94
AN:
32736
American (AMR)
AF:
0.00580
AC:
259
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
30
AN:
25912
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39534
South Asian (SAS)
AF:
0.00141
AC:
121
AN:
85540
European-Finnish (FIN)
AF:
0.0409
AC:
2185
AN:
53396
Middle Eastern (MID)
AF:
0.000874
AC:
5
AN:
5718
European-Non Finnish (NFE)
AF:
0.0217
AC:
23377
AN:
1079718
Other (OTH)
AF:
0.0137
AC:
810
AN:
59180
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1322
2645
3967
5290
6612
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
862
1724
2586
3448
4310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2156
AN:
152266
Hom.:
28
Cov.:
32
AF XY:
0.0149
AC XY:
1108
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00438
AC:
182
AN:
41536
American (AMR)
AF:
0.00830
AC:
127
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4826
European-Finnish (FIN)
AF:
0.0409
AC:
434
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0200
AC:
1357
AN:
68018
Other (OTH)
AF:
0.0109
AC:
23
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
119
238
358
477
596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00692
Hom.:
2
Bravo
AF:
0.0113
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Apr 09, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Dowling-Degos disease 2 Benign:1
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.0
DANN
Benign
0.59
PhyloP100
1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139014980; hg19: chr20-30804535; API